The impact of anti-angiogenic agents on cancer therapy Dieter Marmé Review 16 September 2003 Pages: 607 - 620
Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas Chang-Dae BaeYeon-Sun SungJoobae Park Original Paper 26 August 2003 Pages: 621 - 630
Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells Angela J. ManthaKathryn E. McFeeJim Dimitroulakos Original Paper 26 August 2003 Pages: 631 - 641
Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients Anusri Tripathi (Bhar)Soma BanerjeeChinmay Kumar Panda Original Paper 03 September 2003 Pages: 642 - 650
Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer Pedro F. EscobarMaurie MarkmanJerome Belinson Original Paper 23 September 2003 Pages: 651 - 654
Superiority of combined chemo-embolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats Hermann BödekerErnst-Jan KamphorstMartin R. Berger Original Paper 26 September 2003 Pages: 655 - 661
Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy Herbert AugustinPeter G. HammererAndreas Erbersdobler Original Paper 26 September 2003 Pages: 662 - 668